An observational study in Cancer, sponsored by Scripps Translational Science Institute. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-11-18.
Sponsored by Scripps Translational Science Institute · Observational
This study is being done to learn more about genetic mutations in cancer cells and to find out how the development of new technologies can increase knowledge of these mutations and possibly predict an individual's response to certain treatments.
Scripps Translational Science Institute is the lead sponsor of 52 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Cancer
Inclusion Criteria:
Determine biomarkers of clinical utility and copy number variants through genetic analysis.
Time frame: four years
This study is completed, as verified in Nov 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Scripps Translational Science Institute